drugset / Trial / NCT06900751
A Study to Assess NEU-627 in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
Phase 1, randomized, double-blind, placebo-controlled study of NEU-627 designed to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect.
Timeline
- Start
- 2025-06-02
- Primary completion
- 2025-10-28
- Completion
- 2025-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NEU-627 | Unknown | — | — |
Indications
No indication recorded.